Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1987 1
1988 1
1989 1
1990 3
1991 4
1992 3
1993 1
1994 4
1995 3
1996 5
1997 7
1998 4
1999 3
2000 3
2001 4
2002 4
2003 4
2004 1
2005 3
2006 7
2007 11
2008 5
2009 4
2010 6
2011 8
2012 9
2013 4
2014 1
2015 8
2016 9
2017 5
2018 6
2019 8
2020 8
2021 0
Text availability
Article attribute
Article type
Publication date

Search Results

150 results
Results by year
Filters applied: . Clear all
Page 1
The transcription factor NFAT5 limits infection-induced type I interferon responses.
Huerga Encabo H, Traveset L, Argilaguet J, Angulo A, Nistal-Villán E, Jaiswal R, Escalante CR, Gekas C, Meyerhans A, Aramburu J, López-Rodríguez C. Huerga Encabo H, et al. Among authors: meyerhans a. J Exp Med. 2020 Mar 2;217(3):jem.20190449. doi: 10.1084/jem.20190449. J Exp Med. 2020. PMID: 31816635 Free PMC article.
Antiviral drug discovery: broad-spectrum drugs from nature.
Martinez JP, Sasse F, Brönstrup M, Diez J, Meyerhans A. Martinez JP, et al. Among authors: meyerhans a. Nat Prod Rep. 2015 Jan;32(1):29-48. doi: 10.1039/c4np00085d. Nat Prod Rep. 2015. PMID: 25315648 Free article. Review.
[Mathematical Modeling of the Intracellular Regulation of Immune Processes].
Grebennikov DS, Donets DO, Orlova OG, Argilaguet J, Meyerhans A, Bocharov GA. Grebennikov DS, et al. Among authors: meyerhans a. Mol Biol (Mosk). 2019 Sep-Oct;53(5):815-829. doi: 10.1134/S0026898419050082. Mol Biol (Mosk). 2019. PMID: 31661480 Free article. Review. Russian.
Assessment of the Feasibility and Safety of Durvalumab for Treatment of Solid Tumors in Patients With HIV-1 Infection: The Phase 2 DURVAST Study.
Gonzalez-Cao M, Morán T, Dalmau J, Garcia-Corbacho J, Bracht JWP, Bernabe R, Juan O, de Castro J, Blanco R, Drozdowskyj A, Argilaguet J, Meyerhans A, Blanco J, Prado JG, Carrillo J, Clotet B, Massuti B, Provencio M, Molina-Vila MA, Mayo de Las Casa C, Garzon M, Cao P, Huang CY, Martinez-Picado J, Rosell R. Gonzalez-Cao M, et al. Among authors: meyerhans a. JAMA Oncol. 2020 Jul 1;6(7):1063-1067. doi: 10.1001/jamaoncol.2020.0465. JAMA Oncol. 2020. PMID: 32271353 Free PMC article. Clinical Trial.
Labyrinthopeptins Exert Broad-Spectrum Antiviral Activity through Lipid-Binding-Mediated Virolysis.
Prochnow H, Rox K, Birudukota NVS, Weichert L, Hotop SK, Klahn P, Mohr K, Franz S, Banda DH, Blockus S, Schreiber J, Haid S, Oeyen M, Martinez JP, Süssmuth RD, Wink J, Meyerhans A, Goffinet C, Messerle M, Schulz TF, Kröger A, Schols D, Pietschmann T, Brönstrup M. Prochnow H, et al. Among authors: meyerhans a. J Virol. 2020 Jan 6;94(2):e01471-19. doi: 10.1128/JVI.01471-19. Print 2020 Jan 6. J Virol. 2020. PMID: 31666384 Free PMC article.
Activation of viral defense signaling in cancer.
Gonzalez-Cao M, Karachaliou N, Santarpia M, Viteri S, Meyerhans A, Rosell R. Gonzalez-Cao M, et al. Among authors: meyerhans a. Ther Adv Med Oncol. 2018 Aug 29;10:1758835918793105. doi: 10.1177/1758835918793105. eCollection 2018. Ther Adv Med Oncol. 2018. PMID: 30181782 Free PMC article. Review.
Prediction of PD-L1 inhibition effects for HIV-infected individuals.
Zheltkova V, Argilaguet J, Peligero C, Bocharov G, Meyerhans A. Zheltkova V, et al. Among authors: meyerhans a. PLoS Comput Biol. 2019 Nov 6;15(11):e1007401. doi: 10.1371/journal.pcbi.1007401. eCollection 2019 Nov. PLoS Comput Biol. 2019. PMID: 31693657 Free PMC article.
150 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page